Skip to main content

NCBiotech News

  • Entrepreneurs seeking investors in their companies heard from four corporate venture capital funds at the CED Life Science Conference panel, “Follow the Money.”
  • A panel of experts at the Life Sciences Forum discussed “Value Based Medicine: The Collision of Innovation and Affordability,” Monday at the North Carolina Biotechnology Center.
  • On the first day of the two-day 2017 CED Life Science Conference, four entrepreneurs with roots at North Carolina State University gathered to provide insight to those seeking to launch a life science startup.
  • Globally renowned cardiologist Robert Califf knew it was a temp job when he left his Duke faculty position to become FDA commissioner, and he says he's glad to be back home.
  • Charlotte-based HepatoSys has received a $366,000 Phase I grant from the federal Small Business Innovation Research (SBIR) program to fund the research. It will team up with Lonza which acquired Triangle Research Labs of Research Triangle Park in June 2016 to explore HepatoSys’ patented technology for rejuvenating donated human livers that aren’t healthy enough for organ transplants.
  • Pfizer has committed to providing $4 million to enable the North Carolina Biotechnology Center to establish and administer a  multi-year academic fellowship program to help advance the state's gene therapy expertise.
  • Professionals involved in the field of precision medicine will gather May 24 and 25 at Duke University’s Fuqua School of Business in Durham for the Precision Medicine World Conference 2017.
  • The North Carolina Biotechnology Center has announced that LabCorp Chairman and CEO David P. King will be the keynote speaker for the March 30 Triad BioNight 2017 gala in Greensboro.
  • Taksta, Cempra’s fusidic acid compound, is proving to be both safe and effective in the treatment of acute bacterial skin and skin structure infections.
  • A venture-backed Cary-based plant health company says agricultural growers can maximize their investments with its patented biological, nutritional seed treatment and other technologies.
  • NCBiotech forum speaker says need for proper land management focused on soil health to increase food production, conserve water resources, and help reduce greenhouse gases.
  • Three experts on soil health will share their knowledge in a down-to-earth discussion on Wednesday, Feb. 22, at the next NC Ag Biotech Professional Forum at the North Carolina Biotechnology Center.
  • A new treatment for Duchenne muscular dystrophy has been approved by the U.S. Food and Drug Administration and will be manufactured in Wilmington, N.C.
  • Lucerno Dynamics, a Morrisville company developing noninvasive sensor technology that can show the effectiveness of radiotracer injections in patients undergoing PET/CT scans, has launched a nationwide study to demonstrate the benefits of its system.
  • Durham-based Baebies Inc. has received clearance from the U.S. Food and Drug Administration to begin marketing a system to screen newborns for four rare but potentially fatal diseases.
  • The North Carolina Biotechnology Center's Piedmont Triad Office and the Advisory Committee for Biotechnology in the Piedmont Triad will host Triad BioNight 2017 on Thursday, March 30.
  • Fifth Annual Ag Biotech Entrepreneurial Showcase Set for May 10-11 By Barry Teater, NCBiotech Writer
  • Reducing the time and cost of postmarketing surveillance is a major aim of TARGET PharmaSolutions, a clinical data company that was spun out of the University of North Carolina at Chapel Hill.
  • Hammock Pharmaceuticals is new pharmaceutical company in Charlotte using a novel drug-delivery technology to improve the effectiveness of traditional medicines for a variety of conditions.
  • The Wilmington-based Marine Bio-Technologies Center of Innovation (MBCOI) will put North Carolina in a regional leadership position to prepare businesses for a global shellfish-industry business competition, thanks to a grant from the private NC IDEA foundation.

Pages

Subscribe to News & Events